Dextech Medical AB
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Public
- Established
- 2004-01-01
- Employees
- 11
- Market Cap
- -
DexTech Medical Secures European Patent for OsteoDex GMP Manufacturing Until 2045
• DexTech Medical has received European patent approval for the GMP manufacturing process of OsteoDex, their lead candidate for treating castration-resistant prostate cancer.
• The newly granted patent extends market exclusivity until 2045, significantly strengthening the company's position in ongoing partnership and licensing negotiations.
• This patent approval represents a critical milestone for the continued clinical development of OsteoDex following its completed Phase 2 trials.
© Copyright 2025. All Rights Reserved by MedPath